The Commission also alleged that Renaissance Health and its owner use false proof in their claims that Isoprex is clinically proven to reduce inflammation and swelling, can relieve pain, and better than other over-the-counter (OTC) drugs.
T
he FTC further alleged that the defendants failed to disclose material connections with the endorsers of Isoprex in their advertising materials, which targeted seniors.
Isoprex is a pill containing primarily of a combination of herbs and spices.
In a statement, FTC Bureau of Consumer Protection Director Andrew Smith said, “When you target older adults with promises that your supplement will relieve pain better than FDA-approved drugs, you’d better have the scientific proof to back that up.”
Smith added, “For help with pain or other health conditions, people should rely on their medical professional, not on an advertisement.”
